Literature DB >> 33850053

CD317 puts the brakes on dendritic cell trafficking to the CNS.

Sarah E Barnes1, May H Han2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33850053      PMCID: PMC8106305          DOI: 10.1073/pnas.2104740118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Authors:  B K Kleinschmidt-DeMasters; Kenneth L Tyler
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

2.  Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

Authors:  Maria del Pilar Martin; Petra D Cravens; Ryan Winger; Elliot M Frohman; Michael K Racke; Todd N Eagar; Scott S Zamvil; Martin S Weber; Bernhard Hemmer; Nitin J Karandikar; B K Kleinschmidt-DeMasters; Olaf Stüve
Journal:  Arch Neurol       Date:  2008-10-13

3.  Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta.

Authors:  Roberto Lande; Valérie Gafa; Barbara Serafini; Elena Giacomini; Andrea Visconti; Maria Elena Remoli; Martina Severa; Marc Parmentier; Giovanni Ristori; Marco Salvetti; Francesca Aloisi; Eliana Marina Coccia
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

4.  Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1.

Authors:  Hanadie Yousef; Cathrin J Czupalla; Davis Lee; Michelle B Chen; Ashley N Burke; Kristy A Zera; Judith Zandstra; Elisabeth Berber; Benoit Lehallier; Vidhu Mathur; Ramesh V Nair; Liana N Bonanno; Andrew C Yang; Todd Peterson; Husein Hadeiba; Taylor Merkel; Jakob Körbelin; Markus Schwaninger; Marion S Buckwalter; Stephen R Quake; Eugene C Butcher; Tony Wyss-Coray
Journal:  Nat Med       Date:  2019-05-13       Impact factor: 53.440

Review 5.  Mechanisms of Tolerance Induction by Dendritic Cells In Vivo.

Authors:  Hitoshi Hasegawa; Takuya Matsumoto
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

Review 6.  What Makes a pDC: Recent Advances in Understanding Plasmacytoid DC Development and Heterogeneity.

Authors:  Andrea Musumeci; Konstantin Lutz; Elena Winheim; Anne Barbara Krug
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

7.  CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity.

Authors:  Navid Manouchehri; Rehana Z Hussain; Petra D Cravens; Ekaterina Esaulova; Maxim N Artyomov; Brian T Edelson; Gregory F Wu; Anne H Cross; Richard Doelger; Nicolas Loof; Todd N Eagar; Thomas G Forsthuber; Laurent Calvier; Joachim Herz; Olaf Stüve
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 8.  Immune surveillance in the central nervous system.

Authors:  Shalina S Ousman; Paul Kubes
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

Review 9.  Plasmacytoid dendritic cell biology and its role in immune-mediated diseases.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Clin Transl Immunology       Date:  2020-05-26

Review 10.  Rituximab for the treatment of multiple sclerosis: a review.

Authors:  Clara Grazia Chisari; Eleonora Sgarlata; Sebastiano Arena; Simona Toscano; Maria Luca; Francesco Patti
Journal:  J Neurol       Date:  2021-01-08       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.